Legal Affairs2020-11-19T22:21:35-08:00

Legal Affairs

Red Light Holland Reports Q1 2025

LOS ANGELES- Red Light Holland, an Ontario-based corporation specializing in the production, growth, and sale of functional mushrooms, mushroom home grow kits, and psilocybin truffles, has announced its financial and operational results for the three ...

Curaleaf Reports Revenue Growth in Q2 2024

LOS ANGELES- Curaleaf Holdings, Inc. reported a net loss of $49.8 million for Q2 2024, bringing its year-to-date losses to over $100 million. Despite these losses, the company achieved a 2% increase in revenue, reaching ...

The Cannabist Reports Mixed Q2 2024 Results

LOS ANGELES- The Cannabist Company Holdings Inc. (OTC: CBSTF), formerly known as Columbia Care, delivered a mixed performance for Q2 2024. The company reported $125 million in revenue, a 2% sequential increase but a drop ...

Verano Holdings Reports Mixed Q2 2024 Results

LOS ANGELES- Verano Holdings Corp. reported mixed financial results for Q2 2024, with revenue reaching $222 million, reflecting a 0.5% increase from the previous quarter but a 5% decline year-over-year. The revenue aligned with the ...

Ascend Wellness Reports Revenue Growth in Q2 2024

LOS ANGELES- Ascend Wellness Holdings, Inc. delivered a mixed performance for Q2 2024, reflecting both revenue gains and profitability pressures. The company reported a 15% year-over-year increase in revenue, reaching $141.5 million. Despite this growth, ...

Green Thumb Industries Reports Strong Q2 2024 Performance

LOS ANGELES- Green Thumb Industries Inc. a Chicago-based cannabis company, posted solid second-quarter results for 2024, with revenue climbing 11% year-over-year to $280 million, exceeding analyst forecasts of $277.36 million. The company’s net income rose ...

atai Life Sciences Reports Q2 2024 Financial Results

LOS ANGELES- atai Life Sciences, a biopharmaceutical company focused on transforming mental health treatment, announced its financial results for the second quarter of 2024 along with updates on its clinical pipeline. The company highlighted significant ...

Subscribe To Our Newsletter

Go to Top